HW
DVAX

Hancock Whitney’s Dynavax Technologies DVAX Stock Holding History

Hancock Whitney’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-22,647
Closed -$281K – 615
2024
Q1 		$281K Sell
22,647
-441
-2% -$5.75K 0.01% 549
2023
Q4 		$323K Sell
23,088
-47
-0.2% -$653 0.01% 533
2023
Q3 		$342K Sell
23,135
-730
-3% -$10.3K 0.01% 498
2023
Q2 		$308K Sell
23,865
-13,326
-36% -$152K 0.01% 528
2023
Q1 		$365K Sell
37,191
-1,320
-3% -$14.1K 0.01% 502
2022
Q4 		$410K Buy
38,511
+6,598
+21% +$76.7K 0.02% 466
2022
Q3 		$333K Sell
31,913
-13,377
-30% -$174K 0.01% 499
2022
Q2 		$570K Sell
45,290
-1,735
-4% -$18.4K 0.02% 403
2022
Q1 		$510K Buy
+47,025
New +$571K 0.02% 457
2020
Q4 		– Sell
-14,258
Closed -$62K – 805
2020
Q3 		$62K Sell
14,258
-5,360
-27% -$38.2K ﹤0.01% 773
2020
Q2 		$174K Buy
+19,618
New +$99.1K 0.01% 721

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hancock Whitney's DVAX Position: Q2 2024 in Review

Hancock Whitney sold out of Dynavax Technologies (DVAX) in Q2 2024, closing a stake of 22,647 shares — an estimated $281K sold.

Hancock Whitney first reported a position in DVAX in Q2 2020 and held it in 11 quarters. The position peaked at $570K in Q2 2022. 238 funds tracked by Wall St. Rank hold DVAX as of Q2 2024.

  • Hancock Whitney reported no remaining Dynavax Technologies position as of Q2 2024 after selling out during the quarter.
  • Hancock Whitney sold 22,647 Dynavax Technologies shares in Q2 2024, an estimated $281K.
  • Hancock Whitney first reported a position in Dynavax Technologies in Q2 2020 and held it in 11 quarters.
  • Hancock Whitney's Dynavax Technologies position peaked at $570K in Q2 2022.
  • 238 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2024.

Based on Hancock Whitney's 13F filing for Q2 2024, filed 13 Aug 2024.